Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy
- 31 July 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 24 (2-3), 235-244
- https://doi.org/10.1016/0166-3542(94)90070-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Neutralizing antibodies to recombinant alpha‐interferon and response to therapy in chronic hepatitis C virus infectionLiver International, 1993
- Antibodies Developing Against a Single Recombinant Interferon Protein May Neutralize Many Other Interferon-α SubtypesJournal of Interferon Research, 1993
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990
- Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infectionHepatology, 1990
- Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSFThe Lancet, 1990
- Interferon antibodies in patients with chronic HBV infection treated with recombinant interferonJournal of Hepatology, 1989
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988
- Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell LeukemiaJNCI Journal of the National Cancer Institute, 1988
- LEUCOCYTE-DERIVED INTERFERON-ALPHA IN PATIENTS WITH ANTIBODIES TO RECOMBINANT IFN-α2bThe Lancet, 1988
- CLINICAL SIGNIFICANCE OF ANTI-IFN-α ANTIBODY TITRES DURING INTERFERON THERAPYThe Lancet, 1987